Type 2 Diabetes and Insulin: An Expanding role for Pharmacists in Implementing Medication Therapy Management Services

Type 2 Diabetes and Insulin: An Expanding Role for Pharmacists in Implementing Medication Therapy Management Services
Please read through the following information and click continue.

ACPE Universal Program Number: 207-000-07-134-L01-P
Release Date: October 14, 2007
Expiration Date: October 14, 2010


Statement of Need
The majority of patients with type 2 diabetes will eventually fail to adequately respond to oral drug therapy alone - recent data suggest that two out of three patients are not achieving glycemic targets with their current therapy. Insulin augmentation or replacement in the form of insulin analogs may be used to reduce glycemic burden and improve patient outcome in patients with type 2 diabetes. Insulin analogs are more physiologic and are available in convenient delivery methods that can be used to enhance patient outcomes.

Pharmacists are an untapped resource in today's health care system: untapped by prescribers making treatment decisions and untapped by patients who might benefit from education and advice about type 2 diabetes and the role of insulin. Pharmacists have frequent contact with patients and are critical in helping patients with type 2 diabetes manage their disease. This educational activity is designed to enhance pharmacists' skills in the management of patients on insulin therapy.

Learning Objectives
Upon successful completion of this activity, the pharmacist should be better able to:

  1. Educate patients about glycemic targets for type 2 diabetes (A1C, PPG, FPG).
  2. Describe steps 1 and 2 of the ADA/EASD consensus treatment algorithm for managing type 2 diabetes.
  3. List the indications for exogenous insulin therapy in patients with type 2 diabetes.
  4. Catalog the benefits and features of insulin analogs, including new rapid-acting and long-acting insulin analogs, as well as premixed insulin analogs.
  5. Define medication management therapy and state how pharmacists can apply this to providing care for patients with type 2 diabetes.
Target Audience
The target audience for this program is pharmacists and pharmacy technicians.

Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:

  • Review the content of the activity.
  • Successfully complete the post-test (10 out of 14 correct answers or higher).
  • You will have two (2) opportunities to successfully complete the activity.

Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.

Fee
There is no fee for this activity.

Commercial Support
Supported by an educational grant from Novo Nordisk Inc.

Accreditation

Pharmacists
ACPE logoNCPA is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 1.5 contact hours (.15 CEUs) of continuing pharmacy education credit under the number 207-000-07-134-H01-P.

 

Faculty
Jonathan G. Marquess, PharmD, CDE, CDM (click on faculty name to view biography)
President
The Institute for Wellness and Education
Woodstock, Georgia

Sharrel L. Pinto, BSPharm, DMM, MS, PhD (click on faculty name to view biography)
Assistant Professor
Director
Pharmaceutical Care and Outcomes Research Laboratory
College of Pharmacy
University of Toledo
Toledo, Ohio

David L. Joffe, BSPharm, CDE, FACA (click on faculty name to view biography)
University of Florida College of Pharmacy
Sweetbay Pharmacy
Editor in Chief
DiabetesinControl.com
St Petersburg, Florida

Disclosure Declaration
It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.

Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.

Software Requirements

PC
Windows 2000
Internet Explorer 5.5 or Firefox
*Adobe Acrobat Reader

MAC
Mac OS 10.2.8
Safari
*Adobe Acrobat Reader

*REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON

 

 

 

 

Continue